Thymosin Alpha-1 Programs Dendritic Cells for Immune Tolerance Through Tryptophan Breakdown

Thymosin alpha-1 activated dendritic cell tryptophan catabolism (IDO pathway), establishing a regulatory immune environment that balances inflammation and tolerance — a sophisticated immune-programming mechanism.

Romani, Luigina et al.·Blood·2006·Strong Evidencein-vitro
RPEP-01181In VitroStrong Evidence2006RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
in-vitro
Evidence
Strong Evidence
Sample
Not reported

What This Study Found

Thymosin alpha-1 activated IDO-mediated tryptophan catabolism in dendritic cells, establishing a regulatory environment with balanced inflammation/tolerance that promotes protective Th1 immunity while maintaining regulatory T-cell suppression — sophisticated immune programming.

Key Numbers

How They Did This

in-vitro study on thymosin-alpha-1, immune-function.

Why This Research Matters

Relevant for thymosin-alpha-1, immune-function, infection.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding Thymosin alpha-1 activated IDO-mediated tryptophan catabolism in dendritic cells, establishing a regulatory environment with balanced inflammation/tol
Evidence Grade:
strong evidence.
Study Age:
Published in 2006.
Original Title:
Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance.
Published In:
Blood, 108(7), 2265-74 (2006)
Database ID:
RPEP-01181

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What was studied?

Thymosin Alpha-1 Programs Dendritic Cells for Immune Tolerance Through Tryptophan Breakdown

What was found?

Thymosin alpha-1 activated dendritic cell tryptophan catabolism (IDO pathway), establishing a regulatory immune environment that balances inflammation and tolerance — a sophisticated immune-programming mechanism.

Read More on RethinkPeptides

Cite This Study

RPEP-01181·https://rethinkpeptides.com/research/RPEP-01181

APA

Romani, Luigina; Bistoni, Francesco; Perruccio, Katia; Montagnoli, Claudia; Gaziano, Roberta; Bozza, Silvia; Bonifazi, Pierluigi; Bistoni, Giovanni; Rasi, Guido; Velardi, Andrea; Fallarino, Francesca; Garaci, Enrico; Puccetti, Paolo. (2006). Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance.. Blood, 108(7), 2265-74.

MLA

Romani, Luigina, et al. "Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance.." Blood, 2006.

RethinkPeptides

RethinkPeptides Research Database. "Thymosin alpha1 activates dendritic cell tryptophan cataboli..." RPEP-01181. Retrieved from https://rethinkpeptides.com/research/romani-2006-thymosin-alpha1-activates-dendritic

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.